SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: jay silberman who wrote (413)11/4/1997 6:25:00 PM
From: tonyt  Read Replies (2) | Respond to of 1972
 
> Who (if anyone) thinks this is Vical's big break?

Vical already licenced its technology to Merck, so I wouldn't call this a big break, however it is further evidence of Vical's technology. It's also significant that Merck's equity investment is at a premium to the market.

Gap up tomorrow!